Related references
Note: Only part of the references are listed.BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
Jeffrey J. Swigris et al.
THORAX (2010)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept An Exploratory, Placebo-controlled Trial
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction
Daniel Kellner et al.
JOURNAL OF UROLOGY (2006)
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis
M. Molina-Molina et al.
THORAX (2006)
Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
HW Yao et al.
RESPIRATION (2006)
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study
Silvia Sookoian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: Assessment by ultrasonic integrated backscatter and biochemical markers
Y Shibasaki et al.
HYPERTENSION RESEARCH (2005)
Repeatability of spirometry in 18,000 adult patients
PL Enright et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Angiotensin II and the fibroproliferative response to acute lung injury
RP Marshall et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats
YH Wei et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice
XP Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension
V Croquet et al.
JOURNAL OF HEPATOLOGY (2002)
Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II
M Papp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model
TE King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
DS Lim et al.
CIRCULATION (2001)
Share Paper
